Hemoglobin A2: The 3.5% Threshold for Beta Thalassemia Trait, and What Throws It Off
In a screening study of 23,485 people, almost 17% had a borderline hemoglobin A2 result between 3.1% and 3.9%, landing in the gray zone where the standard threshold for diagnosing beta thalassemia trait stops working cleanly.
Hemoglobin A2 (HbA2) is a tiny fraction of the hemoglobin in your blood, normally around 2% to 3% of the total. It gets measured because it goes up in beta thalassemia trait, the inherited condition where one of your two beta-globin genes is broken. A single number above 3.5% does most of the diagnostic work.
The trouble is that several common conditions can push that number in either direction, and a result on the borderline can be either a real carrier or noise.
What HbA2 Actually Is
Adult hemoglobin comes in three forms: HbA (the dominant one, made of two alpha and two beta chains), HbA2 (two alpha and two delta chains), and HbF (fetal hemoglobin, two alpha and two gamma chains, near zero in healthy adults). In healthy iron-replete adults, HbA2 normally sits below 3.5% of total hemoglobin, with most people falling well under that cutoff.
The reason adults make so little HbA2 is structural: delta-globin gene transcription is regulated by transcription factor binding to its promoter, and certain promoter mutations are required to increase delta-chain output above its normally low baseline.
In beta thalassemia trait, the broken beta-globin gene leaves an excess of alpha chains floating around. Those extra alphas pair up with whatever delta chains exist, producing more HbA2. The mechanism is post-translational: HbA2 climbs not because the delta gene is suddenly more active, but because the raw material is more available.
The 3.5% Threshold
Across screening programs and laboratory guidelines, HbA2 above 3.5% is the standard cutoff for diagnosing beta thalassemia trait.
In a series of more than 600 confirmed carriers across 32 different beta-globin mutations, severe carriers (β° or severe β+) had HbA2 between 4.5% and 5.5%, while milder β+ carriers ran between 3.6% and 4.2%. Carriers with silent mutations had still lower values.
The Canadian carrier-screening guideline lays out the standard workflow: a complete blood count, hemoglobin electrophoresis or HPLC with HbA2 quantitation, and a serum ferritin to rule out iron deficiency at the same time. If HbA2 is elevated and the partner has any indication, both should be tested, and a couple positive on both sides should be referred for genetic counseling.
Typical HbA2 Ranges
| Group | Typical HbA2 % | Source |
|---|---|---|
| Healthy adults | Below 3.5% | |
| β-thalassemia trait, mild β+ | 3.6% to 4.2% | |
| β-thalassemia trait, severe β+ or β° | 4.5% to 5.5% | |
| Borderline (gray zone) | 3.1% to 3.9% |
Instalab's Hemoglobin Electrophoresis ($93) is the test that quantifies HbA2 along with HbA, HbF, and any abnormal variants. If you have a borderline value, ancestry from a high-prevalence region, or family history of thalassemia, this is the panel that gets you a usable number.
The Borderline Problem
Where HbA2 gets messy is the 3.1% to 3.9% gray zone.
In the 23,485-person Italian screening cohort, 3,934 people (about 17%) had a borderline HbA2 between 3.1 and 3.9%. Among 410 of those borderlines who were the partner of a confirmed beta thalassemia carrier, 22.9% turned out on molecular testing to carry a real defect: most often a beta-globin mutation, but also delta-globin variants, beta-promoter mutations, and alpha-globin triplications.
Translation: a borderline HbA2 isn't reassuring. In a higher-risk population, roughly 1 in 5 borderline cases will turn out to be a true carrier on DNA testing.
When HbA2 Reads Falsely Low
Several conditions push HbA2 below where it should be, which can mask a real carrier. The two most common are iron deficiency and alpha-thalassemia.
In a 1,356-person Arab premarital screening study, subjects with iron deficiency had a mean HbA2 of 2.30%, about 0.2 percentage points lower than non-deficient subjects at 2.50% (P<0.0001). Subjects with alpha-thalassemia trait had a mean HbA2 of 2.43%, about 0.13 percentage points lower than those without.
Either suppression alone is small, but stacked together they can drop someone from 3.5% (clearly diagnostic) to 3.2% (borderline). The authors estimated that 2.6% of their cohort was at real risk of a false-negative beta thalassemia screen because of these effects.
Iron deficiency can lower HbA2 enough to mask carrier status in some patients, and a 463-person study of beta thalassemia trait carriers found iron deficiency common enough that iron therapy is a standard recommendation when ID is detected alongside the trait.
The practical takeaway: if HbA2 is borderline or unexpectedly normal in someone with low MCV or microcytosis, check iron status before concluding the screen is negative.
When HbA2 Reads Falsely High
In the other direction, megaloblastic anemia can raise HbA2 in some patients, with the highest values seen in those with the most severe anemia. The standard workup therefore pairs HbA2 measurement with vitamin B12 and folate status to flag any deficiency that could shift the result.
A study of HbA2 across hematologic disorders, which combined 300 healthy controls with 904 patients, documented the pattern directly: HbA2 was elevated in megaloblastic anemia and beta thalassemia heterozygotes, low in iron-deficiency anemia, hereditary persistence of fetal hemoglobin, and Hb H disease. Within beta thalassemia trait specifically, both iron deficiency and folate deficiency suppressed HbA2 levels, while B12 deficiency alone did not. The takeaway is that HbA2 should always be interpreted alongside iron studies, B12, folate, and recent medication history.
Lab Method Matters
Two methods quantify HbA2 cleanly: HPLC (high-performance liquid chromatography) and capillary electrophoresis. Both are precise.
HPLC, however, can be inaccurate in the presence of sickle cell trait, where the percentage tends to be overestimated. The measurement is stable for about a week after the blood draw, but accuracy degrades by two weeks in most samples.
Lab-to-lab variation matters too. The 3.5% threshold assumes a calibrated, standardized assay. If you have a borderline result, the most common quick check is to repeat the test in a reference lab.
What the Research Says About Next Steps
When the first HbA2 lands in the 3.1% to 3.9% range and red cell indices are abnormal, the standard next step is molecular testing of the beta-globin gene (and often delta- and alpha-globin). Iron deficiency, B12, and folate deficiency should be corrected first when present, and the HbA2 repeated.
For couples planning a pregnancy where one or both partners have abnormal indices or borderline HbA2, the recommendation is to test both, and to refer to genetic counseling if both turn out to carry significant variants. The reason: two carriers have a 25% chance per pregnancy of a child with significant disease, including transfusion-dependent thalassemia.
What Your HbA2 Result Means in Context
A clean HbA2 above 3.5% in an iron-replete person with otherwise unremarkable B12 and folate is strong evidence for beta thalassemia trait. A clean HbA2 below 3.0% in someone with normal red cell indices is reassuring. The work happens in the gray zone, where iron status, vitamin status, alpha-thalassemia, and lab method all interact with the number.
If the goal is screening (you have ancestry from a high-prevalence region, or your partner is a carrier, or you have unexplained microcytic anemia), the test that matters is hemoglobin electrophoresis or HPLC with HbA2 quantitation, drawn alongside ferritin, B12, and folate so the result can be interpreted clean.
No referral needed. Results reviewed by a physician.